Crescent Biopharma (CBIO) Short-term Investments (2013 - 2017)

Crescent Biopharma (CBIO) has 5 years of Short-term Investments data on file, last reported at $5219.0 in Q1 2017.

• Short-term Investments for Q1 2017 came in at $5219.0, down 24.46% year-over-year; the trailing twelve-month figure through Mar 2017 was $5219.0 (down 24.46% YoY), and the FY2016 annual result was $10649.0, up 14.88% from the prior year.
• Short-term Investments slipped to $5219.0 in Q1 2017 per CBIO's latest filing, from $10649.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $16293.0 in Q4 2014 and troughed at $1000.0 in Q4 2013.
• A 5-year average of $8766.7 and a median of $9948.0 in 2015 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2014 and 2016: Short-term Investments jumped 1529.3% in 2014, then plunged 92.17% in 2016.
• A 5-year view of Short-term Investments shows it stood at $1000.0 in 2013, then jumped by 1529.3% to $16293.0 in 2014, then plunged by 43.1% to $9270.0 in 2015, then grew by 14.88% to $10649.0 in 2016, then tumbled by 50.99% to $5219.0 in 2017.
• Business Quant data shows CBIO's Short-term Investments at $5219.0 in Q1 2017, $10649.0 in Q4 2016, and $1000.0 in Q2 2016.